🇺🇸 FDA

Intelligence · Clinical Pipeline

United Therapeutics Europe Pipeline

All ClinicalTrials.gov programs at United Therapeutics Europe — phase, modality, and trial IDs.

Programs
336

Quick answer

United Therapeutics Europe has 336 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Oral versus topical antibioitics

    United Therapeutics Europe Ltd

    Chronic Rhinosinusitis (Diagnosis)

    phase 2 small molecule terminated

    1 trial

  2. Oxytocin

    United Therapeutics Europe Ltd

    Alcohol Use Disorder

    phase 2 small molecule completed

    1 trial

  3. PT150

    United Therapeutics Europe Ltd

    PTSD - Post Traumatic Stress Disorder

    phase 2 small molecule active

    1 trial

  4. PUL-042 Inhalation Solution

    United Therapeutics Europe Ltd

    COVID-19

    phase 2 small molecule completed

    2 trials

  5. Paclitaxel

    United Therapeutics Europe Ltd

    Clinical Stage III Gastric Cancer AJCC v8

    phase 2 small molecule active

    1 trial

  6. Palbociclib 125Mg Tab

    United Therapeutics Europe Ltd

    ER+ Breast Cancer

    phase 2 small molecule active

    1 trial

  7. Palmidrol

    United Therapeutics Europe Ltd

    Chemotherapy-Induced Peripheral Neuropathy

    phase 2 small molecule active

    1 trial

  8. Panitumumab

    United Therapeutics Europe Ltd

    Metastatic Colon Adenocarcinoma

    phase 2 mab active

    1 trial

  9. Parenteral Remodulin (treprostinil) injection

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 2 small molecule terminated

    1 trial

  10. Pembrolizumab

    United Therapeutics Europe Ltd

    Pancreatic Cancer

    phase 2 small molecule active

    1 trial

  11. Pembrolizumab

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 small molecule active

    1 trial

  12. Pembrolizumab

    United Therapeutics Europe Ltd

    Castration-resistant Prostate Cancer

    phase 2 small molecule active

    1 trial

  13. Pembrolizumab

    United Therapeutics Europe Ltd

    Metastatic Small Intestinal Adenocarcinoma

    phase 2 mab active

    1 trial

  14. Pembrolizumab

    United Therapeutics Europe Ltd

    Triple Negative Breast Cancer

    phase 2 small molecule active

    1 trial

  15. Pembrolizumab (200mg IV for 30 minutes

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 small molecule active

    1 trial

  16. Pirfenidone

    United Therapeutics Europe Ltd

    Cardiac Failure

    phase 2 small molecule completed

    1 trial

  17. Placebo

    United Therapeutics Europe Ltd

    Influenza

    phase 2 small molecule completed

    1 trial

  18. Placebo Infusion

    United Therapeutics Europe Ltd

    Brain Injuries, Traumatic

    phase 2 mab active

    1 trial

  19. Placebo oral capsule

    United Therapeutics Europe Ltd

    Osteoarthritis, Knee

    phase 2 small molecule completed

    1 trial

  20. ProSpare

    United Therapeutics Europe Ltd

    Cancer

    phase 2 other active

    1 trial

  21. Prostate alone IMRT

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 2 other active

    1 trial

  22. Psilocybin (Usona Institute)

    United Therapeutics Europe Ltd

    Spinal Cord Injury

    phase 2 small molecule active

    1 trial

  23. Pulmonary Rehabilitation (PR)

    United Therapeutics Europe Ltd

    Non-small Cell Lung Cancer Stage III

    phase 2 other active

    1 trial

  24. Qutenza

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    phase 2 small molecule completed

    1 trial

  25. Qutenza (8% capsaicin)

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    phase 2 small molecule completed

    1 trial

  26. RTS,S/AS01B (50mcg of RTS,S and standard adult dose of AS01)

    United Therapeutics Europe Ltd

    Plasmodium Falciparum Malaria

    phase 2 mab completed

    1 trial

  27. Radiation: 131I-MIBG

    United Therapeutics Europe Ltd

    Neuroblastoma

    phase 2 small molecule active

    1 trial

  28. Ralinepag

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 2 small molecule completed

    1 trial

  29. Recombinant human growth hormone

    United Therapeutics Europe Ltd

    Gulf War Syndrome

    phase 2 small molecule active

    1 trial

  30. Regorafenib

    United Therapeutics Europe Ltd

    Adenocarcinoma of the Gastroesophageal Junction

    phase 2 small molecule terminated

    1 trial

  31. Riboflavin

    United Therapeutics Europe Ltd

    Keratolysis

    phase 2 small molecule completed

    1 trial

  32. Rituximab

    United Therapeutics Europe Ltd

    Fatigue

    phase 2 mab completed

    1 trial

  33. Roginolisib

    United Therapeutics Europe Ltd

    Leukemia

    phase 2 small molecule active

    1 trial

  34. Ropivacaine injection

    United Therapeutics Europe Ltd

    Stress Disorders, Post-Traumatic

    phase 2 small molecule active

    2 trials

  35. Rucaparib

    United Therapeutics Europe Ltd

    Cervical Cancer

    phase 2 small molecule terminated

    1 trial

  36. S-1

    United Therapeutics Europe Ltd

    Advanced Non-Small Cell Lung Cancer

    phase 2 small molecule completed

    2 trials

  37. S-1

    United Therapeutics Europe Ltd

    Locally Advanced or Metastatic Pancreatic Cancer

    phase 2 small molecule completed

    1 trial

  38. SARS-CoV-2 convalescent plasma

    United Therapeutics Europe Ltd

    SARS-CoV 2

    phase 2 mab completed

    1 trial

  39. SPINALON (buspirone + levodopa + cardidopa)

    United Therapeutics Europe Ltd

    Spinal Cord Injury

    phase 2 small molecule completed

    1 trial

  40. SRX246

    United Therapeutics Europe Ltd

    PTSD

    phase 2 small molecule terminated

    1 trial

  41. SX-682

    United Therapeutics Europe Ltd

    Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

    phase 2 small molecule active

    1 trial

  42. Sargramostim

    United Therapeutics Europe Ltd

    Covid19

    phase 2 small molecule completed

    1 trial

  43. Sargramostim

    United Therapeutics Europe Ltd

    COVID-19

    phase 2 small molecule completed

    1 trial

  44. Self-hypnotic Relaxation

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 other completed

    1 trial

  45. Selpercatinib Monotherapy

    United Therapeutics Europe Ltd

    Differentiated Thyroid Cancer

    phase 2 small molecule active

    1 trial

  46. Selumetinib

    United Therapeutics Europe Ltd

    Malignant Peripheral Nerve Sheath Tumors

    phase 2 small molecule completed

    1 trial

  47. Selumetinib

    United Therapeutics Europe Ltd

    Metastatic Thyroid Gland Carcinoma

    phase 2 small molecule completed

    1 trial

  48. Semaglutide

    United Therapeutics Europe Ltd

    Cardiomyopathy

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does United Therapeutics Europe have?

336 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.